Search

Search Results

• 

  Hematological, hepatic, and renal adverse effects of high dose methotrexate injection (50 mg weekly) in severe psoriasis cases

  Adissa Tiara Yulinvia, Prasta Bayu Putra, Niken Trisnowati, Sunardi Radiono

  29-03-2019

  https://doi.org/10.4081/dr.2019.8053

  1232

  PDF: 527
• 

  Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis

  Martina Burlando, Chiara Craviotto, Luca Carmisciano , Gerolamo Bianchi, Aurora Parodi

  08-10-2021

  https://doi.org/10.4081/dr.2021.9111

  849

  PDF: 476

  HTML: 16
• 

  Tight junctions in Hailey-Hailey and Darier’s diseases

  Laura Raiko, Pekka Leinonen, Päivi Hägg, Juha Peltonen, Aarne Oikarinen, Sirkku Peltonen

  e1

  13-11-2009

  https://doi.org/10.4081/dr.2009.e1

  1693

  PDF: 691

  HTML: 1736

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  514

  PDF: 327

  HTML: 25

• Photosensitive psoriasis mimicking cutaneous lupus erythematosus: a case report

  Gabrielė Jonauskaitė, Valentina Rimkienė, Jūratė Barauskienė, Tadas Raudonis

  26-02-2026

  https://doi.org/10.4081/dr.2026.10794

  795

  PDF: 353

• 24 | IXEKIZUMAB WITH OR WITHOUT TIRZEPATIDE IN ADULTS WITH PSORIASIS AND OVERWEIGHT OR OBESITY: THE TOGETHER-PSO PHASE 3B RANDOMIZED CLINICAL TRIAL E. Filippi¹, M. Lebwohl², A. Blauvelt³, C. Kartman⁴, C. Leatherwood⁴, K. Gordon⁵, N. Sattar⁶, L. Puig⁷, J. Merola⁸, K. Siu⁴, R. Wang⁴, L. Sun⁴, A. Leung⁹, N. Somani⁴, M. Rueda⁴, A. Cardoso⁴, M. Genovese⁴, A. Armstrong¹⁰, B. Strober¹¹ | ¹Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; ²Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; ³Blauvelt Consulting, LLC, Annapolis, MD, USA; ⁴Eli Lilly and Company, Indianapolis, IN, USA; ⁵Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA; ⁶School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁷Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain; ⁸Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ⁹Syneos Health, Morrisville, NC, USA; ¹⁰Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA; ¹¹Department of Dermatology, Yale University School of Medicine, New Haven, CT, Central Connecticut Dermatology Research, Cromwell, CT, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11086

  97

  PDF: 31

• Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis

  Davide Bertolla, Andrea Conti

  30-01-2026

  https://doi.org/10.4081/dr.2026.10240

  1034

  PDF: 433

• When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

  Chiara Del Re, Vincenzo Filastro, Gaia Fasano, Giancarlo Valenti, Domenico D'Amico

  11-09-2026

  https://doi.org/10.4081/dr.2026.10808

  392

  PDF: 167

• The top 100 most cited articles in acne vulgaris: a bibliometric analysis

  Sapir Itzhaki Gabay, Barak Zlakishvili, Yuliya Valdman-Grinshpoun , Amir Horev

  15-02-2024

  https://doi.org/10.4081/dr.2024.9886

  3360

  PDF: 615

  SUPPLEMENTARY MATERIAL: 200

  HTML: 26
• 

  Slow responder against methotrexate 50 mg intramuscular in severe psoriatic patients: A case series

  Niken Kusumaningrum, Danar Wicaksono, Dwi Retno Adi Winarni, Yohanes Widodo Wirohadidjojo, Sunardi Radiono

  01-04-2019

  https://doi.org/10.4081/dr.2019.8080

  1111

  PDF: 469

• 31 | DRUG ECONOMIC ANALYSIS OF THE DOSE SPACING OF BIOLOGICAL DRUGS IN ATOPIC DERMATITIS AND PSORIASIS A. Filoni¹, L. Pietroleonardo¹, P. Stasi², M. Spagnolo², F. Scicchitano², S. Pelle³, M. Congedo¹ | ¹UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; ²Servizio Farmaceutico Distrettuale. Asl Lecce, Italy; ³Dermatology Outpatient Unit, Asl Lecce, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11064

  85

  PDF: 32

• Domain-specific Skindex-29 response under biologics, conventional systemics, and phototherapy: a four-time-point real-world brief report

  Ardea Milidrag, Milena Zlatanović, Vesna Miličić, Gordana Ristić, Kristina Andrić, Ana Ravić-Nikolić

  22-09-2026

  https://doi.org/10.4081/dr.2026.10651

  86

  PDF: 70
• 

  Autoinflammatory diseases: what is behind them and what is new?

  Michele Maalouly, Serena Saade, Mazen Kurban

  29-12-2022

  https://doi.org/10.4081/dr.2023.9625

  1881

  PDF: 594

  HTML: 163
• 

  Impact of pandemic COVID-19 on dermatology and venereology outpatient clinic in a tertiary referral hospital in Yogyakarta, Indonesia

  Alessandro Alfieri, Flandiana Yogianti

  06-10-2021

  https://doi.org/10.4081/dr.2021.9381

  2604

  PDF: 570

  HTML: 26

• 25 | EARLY AND MAINTAINED TREAT-TO-TARGET RESPONSE WITH IXEKIZUMAB UP TO 5 YEARS IN MODERATE-TO-SEVERE PSORIASIS: A POST-HOC ANALYSIS OF UNCOVER-3 E. Filippi¹, A. Armstrong², J. F. Merola³, M. Megna⁴, X. Man⁵, M. Honma⁶, J-M. Carrascosa⁷, R. Chughtai⁷, K. Fotiou⁸, S. Sabatino⁸, M. Ngantcha⁸, A. Pinter⁹ | ¹Eli Lilly Italia S.p.A, Florence, Italy; ²University of California, Los Angeles, CA, USA; ³University of Texas Southwestern Medical Center, Dallas, TX, USA; ⁴University of Naples Federico II, Naples, Italy; ⁵Zhejiang University, Hangzhou, China; ⁶Asahikawa Medical University, Asahikawa, Japan; ⁷Hospital Germans Trias, Universitat Autònoma de Barcelona, Barcelona, Spain; ⁸Eli Lilly and Company, Indianapolis, IN, USA; ⁹University Hospital Frankfurt, Frankfurt, Germany

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11087

  98

  PDF: 21
• 

  Oral warty dyskeratoma: An unusual presentation

  Hamid Reza Ghasemi Basir, Pedram Alirezaei, Baharereh Ebrahimi, Sina Khanali

  25-06-2020

  https://doi.org/10.4081/dr.2020.8236

  1311

  PDF: 604

  HTML: 285
• 

  Early morphea simulating patch-stage mycosis fungoides in two cases

  Hamid R. Ghasemi Basir, Pedram Alirezaei, Aliasghar Rezanejad, Sajjad Daneshyar

  23-04-2018

  https://doi.org/10.4081/dr.2018.7477

  1596

  PDF: 728

  HTML: 131

• Does the response to bimekizumab vary according to previous therapy with methotrexate versus cyclosporine?

  Ilaria Salvi, Alexandra M. G. Brunasso, Franco Castelli, Andrea Michelerio, Paolo Pella, Marco Rubatto, Paolo Dapavo, Emanuele Cozzani, Martina Burlando

  20-03-2026

  https://doi.org/10.4081/dr.2026.10236

  353

  PDF: 300
• 

  Epidermolysis bullosa acquisita: current diagnosis and therapy

  Christine R. Mehren, Robert Gniadecki

  e38

  28-11-2011

  https://doi.org/10.4081/dr.2011.e38

  1654

  PDF: 917

  HTML: 133

• The humanistic burden of atopic dermatitis in Greece: a cross-sectional study

  Georgia Kourlaba, Katerina Lioliou, Garyfallia Stefanou, Soultana Koukopoulou, Eirinaios Vamvakousis, Dimitrios Ioannides

  09-04-2025

  https://doi.org/10.4081/dr.2025.10164

  925

  PDF: 459

  SUPPLEMENTARY MATERIAL: 59

  HTML: 17

• Association between lifestyle and skin moisturizing function in community-dwelling older adults

  Ryosuke Oizumi, Risa Shibata

  05-04-2024

  https://doi.org/10.4081/dr.2024.9964

  1020

  PDF: 649

  HTML: 57

• Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a pediatric population

  Anna Dattolo, Francesca Sampogna, Simona Mastroeni, Luca Fania, Davide Ciccone, Damiano Abeni

  16-10-2024

  https://doi.org/10.4081/dr.2024.10086

  890

  PDF: 545

  HTML: 39

• The association between serum leptin level and the atherogenic index of plasma in psoriatic patients

  Samer A. Dhaher, Budoor O. Yousif, Nazar S. Haddad

  26-08-2026

  https://doi.org/10.4081/dr.2026.10817

  129

  PDF: 94

  SUPPLEMENTARY MATERIAL: 20

• Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum

  Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole

  03-02-2026

  https://doi.org/10.4081/dr.2026.10314

  624

  PDF: 415
• 

  The anxiety and depression disorder in adults with atopic dermatitis: experience of a dermatology hospital

  Ngo Minh Vinh , Vu Thi Thuy Trang, Luong Nguyen Dac Thuy, Huynh Thi Xuan Tam , Le Thi Thuy Hang , Pham Van Bac

  06-07-2022

  https://doi.org/10.4081/dr.2022.9524

  2159

  PDF: 811

  HTML: 34